A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
Kokado
Y
Y
Department of Urology, Osaka University Hospital, Japan.
Ishibashi
M
M
Jiang
H
H
Takahara
S
S
Sonoda
T
T
D000328:Adult; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D014019:Tissue Donors
D003524:Cyclosporins; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone; D003404:Creatinine